Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: An AIDS Clinical Trials Group clinical study

Journal of Clinical Oncology

Volumn 20, Issue 15, 2002, Pages 3236-3241

  Evans, Scott R ^a   Krown, Susan E ^a   Testa, Marcia A ^a   Cooley, Timothy P ^a   Von Roenn, Jamie H ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ETOPOSIDE; PACLITAXEL;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; KAPOSI SARCOMA; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, ORAL; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ETOPOSIDE; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SARCOMA, KAPOSI; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036682006     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.12.038     Document Type: Article

References (24)

1. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
2. Kaposi's sarcoma in HIV infection: Impact on opportunistic infections and survival
3. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy
4. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome
5. Single agent or combination chemotherapy of Kaposi's sarcoma (KS) in acquired immune deficiency syndrome (AIDS)
6. Vincristine and Kaposi's sarcoma in the acquired immunodeficiency syndrome
7. Phase II study of epirubicin in the treatment of Kaposi's sarcoma and AIDS (EKS)
8. Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial
9. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin and vinblastine
10. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
11. Pegylatedliposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
12. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
13. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
14. Phase Il trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
15. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy
16. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: A phase I multicenter trial of the AIDS Clinical Trials Group
17. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
18. Optimal two stage design of phase II clinical trials
19. AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification
20. The clinical pharmacology of etoposide
21. Prolonged administration of single-agent oral etoposide in patients with untreated small cell lung cancer (SCLC)
22. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy
23. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals: Multicenter AIDS Cohort Study
24. Cancer incidence in the African population of Harare, Zimbabwe: Second results from the cancer registry 1993-1995